Submission Details
| 510(k) Number | K173792 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 14, 2017 |
| Decision Date | March 13, 2018 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K173792 is an FDA 510(k) clearance for the EliA PR3s Immunoassay; EliA MPOs Immunoassay; EliA GBM Immunoassay, a Test System, Antineutrophil Cytoplasmic Antibodies (anca) (Class II — Special Controls, product code MOB), submitted by Phadia AB (Uppsala, SE). The FDA issued a Cleared decision on March 13, 2018, 89 days after receiving the submission on December 14, 2017. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5660.
| 510(k) Number | K173792 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 14, 2017 |
| Decision Date | March 13, 2018 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | MOB — Test System, Antineutrophil Cytoplasmic Antibodies (anca) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5660 |